Theoretical Investigation of \(^{64}\)Cu Production in a \(p\)-induced Reaction: Medical and Industrial Perspectives
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Copper-64 (\(^{64}\)Cu) is a promising theranostic radionuclide owing to its dual decay modes (\(\beta ^+\): 17.4\(\%\), \(\beta ^-\): 38.5\(\%\), \(e^-\) capture: 44.1\(\%\)) and 12.7 h half-life, enabling both PET imaging and targeted radiotherapy. This work presents a theoretical study of \(^{64}\)Cu production via the \(^{64}\)Ni(\(p,n\))\(^{64}\)Cu reaction using PACE4, EMPIRE-3.2.2, and TALYS-1.96 codes. Reaction mechanisms, excitation functions, and yield predictions were analyzed to identify optimal conditions for medical cyclotron production. The simulations indicate an optimal proton energy range of 10–15 MeV, which maximizes the \(^{64}\)Cu yield while minimizing contaminants. Calculated excitation functions and thick-target yields show good agreement with experimental data, confirming model reliability for the reaction. The results provide theoretical guidance for efficient \(^{64}\)Cu production and target design. Given its established clinical utility in radiopharmaceuticals such as \(^{64}\)Cu-DOTATATE and \(^{64}\)Cu-ATSM, and its industrial role as a radiotracer, \(^{64}\)Cu continues to emerge as a key radionuclide bridging nuclear physics, radiochemistry, and applied science. Abstract Published by the Jagiellonian University 2026 authors
Fields of Study & Subjects
Nuclear physics research studies
Radiopharmaceutical Chemistry and Applications
Nuclear Physics and Applications
Publication details
- Journal / source
- Acta Physica Polonica B Proceedings Supplement
- Volume
- 19
- Issue
- 1
- Pages
- 1–1
- Publication date
- 31 March 2026
- Language
- EN